WebGoldfinch Bio 3,437 followers on LinkedIn. We aspire to save kidneys and end dialysis by delivering disease-modifying precision medicines for patients. With our sole focus on kidney diseases, we aspire to be the world’s leading precision medicine kidney company. There are few therapeutic options that target the underlying cause of disease. Our … WebDec 6, 2024 · Jacobs, who most recently served as CSO of Ardelyx, Inc., brings to Goldfinch Bio over 25 years of experience leading drug discovery and development efforts across …
Goldfinch Bio Appoints Jeff W. Jacobs as CSO
WebDec 6, 2024 · — Dr. Jacobs brings expansive small molecule discovery and development leadership expertise, Including experience leading discovery and development strategies for new medicines for kidney disease — — Goldfinch Bio is advancing precision kidney medicines, including… WebMar 14, 2024 · Currently, Jeffrey Goldfinch works as a Marketing Officer at University of Tasmania. Work Experience. Manager, Loyalty Marketing. Palace Cinemas. 2015-2024. Acquisitions Marketing Executiv. Nine Entertainment Company. 2011-2015. CRM The Age Marketing Coordinator. The Age. 2009-2011. Education. breakfast food truck phoenix az
Goldfinch Bio Strengthens Leadership Team with Appointment of Jeff …
WebJan 27, 2024 · Kyle LaHucik Associate Editor Goldfinch Bio, attempting to make treatments for kidney diseases and diabetic nephropathy, is shutting down. President and CEO Tony Johnson confirmed to Endpoints... WebContact Email [email protected] Phone Number (617)337-4200 Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease. WebIn his past career he occupied the position of Senior Vice President-Technical Operations at Ardelyx, Inc., Chief Scientific Officer for Goldfinch Bio, Inc., Principal at Affymax, Inc., … costco sealy twin mattress review